Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus
- PMID: 8557181
- DOI: 10.1002/gepi.1370120506
Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus
Abstract
Apolipoprotein E (APOE) plays an important role in the multifactorial etiology of both cardiovascular disease and Alzheimer's disease. Polymerase chain reaction (PCR) was used to investigate the APOE gene polymorphism in 335 unrelated Greek Cypriots living on the island of Cyprus. For the most common APOE genotypes, the Greek Cypriots followed the general Caucasian European pattern of having higher genotypic frequencies of E3/3, followed by E3/4, and then E2/3. Among the European populations compared, Greek Cypriots exhibited the lowest relative frequency of the E3/4 genotype (12.83%). Also, the relative frequencies of the E2 and E4 alleles in Greek Cypriots were among the lowest around the world (5.4% and 7.0%, respectively). This was also demonstrated by using the complete and the average clustering methods of analysis where the APOE allele relative frequencies in Greek Cypriots were compared to 46 other populations. The Greek Cypriot population in these analyses clustered with populations mainly from south Europe and Japan which have low E2 and E4 allele frequencies. The Greek Cypriot population will be studied further for elucidating the effect(s) and the role of APOE in cardiovascular disease and the APOE4 allele as a possible metabolic factor affecting the rate of expression of both Alzheimer's disease and vascular dementia.
Similar articles
-
Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.Diabetes Nutr Metab. 2004 Oct;17(5):267-74. Diabetes Nutr Metab. 2004. PMID: 16295048
-
Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.Maturitas. 2004 Jul 15;48(3):259-64. doi: 10.1016/j.maturitas.2004.01.008. Maturitas. 2004. PMID: 15207892
-
[Apolipoprotein E genotypes in patients investigated for dementia].Ugeskr Laeger. 1997 Sep 15;159(38):5658-61. Ugeskr Laeger. 1997. PMID: 9340872 Danish.
-
Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.Hum Biol. 1995 Apr;67(2):195-215. Hum Biol. 1995. PMID: 7729825 Review.
-
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.Exp Gerontol. 2004 Oct;39(10):1567-73. doi: 10.1016/j.exger.2004.07.006. Exp Gerontol. 2004. PMID: 15501028 Review.
Cited by
-
Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts.Mol Biol Rep. 2008 Dec;35(4):495-9. doi: 10.1007/s11033-007-9113-3. Epub 2007 Jun 27. Mol Biol Rep. 2008. PMID: 17594534
-
Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.Neurochem Res. 1998 Mar;23(3):369-76. doi: 10.1023/a:1022461601609. Neurochem Res. 1998. PMID: 9482249 Review.
-
Alzheimer Disease Associated Loci: APOE Single Nucleotide Polymorphisms in Marmara Region.Biomedicines. 2024 Apr 27;12(5):968. doi: 10.3390/biomedicines12050968. Biomedicines. 2024. PMID: 38790930 Free PMC article.
-
ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size.Eur J Epidemiol. 2001;17(8):707-13. doi: 10.1023/a:1015618216828. Eur J Epidemiol. 2001. PMID: 12086087
-
Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia.Curr Genomics. 2017 Oct;18(5):430-441. doi: 10.2174/1389202918666170608093833. Curr Genomics. 2017. PMID: 29081698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous